Surgery is the main treatment for curing gastric cancer. Early diagnosis provides an
excellent survival outcome via an improved detection of early gastric cancer and an …

Background Gastric carcinoma (GC) is one of the highest cancer-mortality diseases with a
high incidence rate in Asia. For surgically unfit but medically fit patients, palliative …

Background Cancer metabolism is emerging as an important focus area in cancer research.
However, the in vitro cell culture conditions under which much cellular metabolism research …

ABSTRACT Ethnopharmacological relevance Traditional Chinese Medicines (TCMs) have
emerged as a promising complementary therapy in the management of prostate cancer …

BACKGROUND As the first-line regimens for the treatment of advanced gastric cancer, both
docetaxel, cisplatin, and 5-fluorouracil (DCF) and epirubicin, cisplatin, and 5-fluorouracil …

Gastric cancer remains a significant health burden worldwide. Most of these malignancies
are diagnosed at an advanced stage and are associated with a grim prognosis. Complete …

Background/Aim: This study assessed the toxicity and activity of biweekly docetaxel and S-1
combination therapy in elderly patients with advanced gastric cancer. Patients and Methods …

目的探讨进展期胃癌中β-tubulinⅢ 和survivin 的表达与多西紫杉醇化疗耐药性关系.
方法回顾性分析74 例接受多西紫杉醇化疗的晚期胃癌患者的临床病理资料 …

Background: This prospective phase II clinical trial evaluated the ef‑ficacy and toxicity of
cisplatin, oral tegafur‑uracil, leu‑covorin, and mitomycin C in patients with recurrent or …

First-line triplet chemotherapy including a taxane may prolong survival in patients with
metastatic esophagogastric cancer. The added toxicity of the taxane might be minimized by …